Sign up to save your podcasts
Or
Share Leveraging Expanded Access and Named-Patient Programs: Best Practices for Small and Emerging Biotech and Pharma Companies
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Leveraging Expanded Access and Named-Patient Programs: Best Practices for Small and Emerging Biotech and Pharma Companies
Date Posted: 03/31/2010 Size: 6.64MB Length: 00:14:32 Thought Leader: Nicky Wisener, Biopharmaceutical Account Manager, Idis In this episode, Ms. Wisener describes how expanded access and named-patient programs can help successfully meet patients' needs while addressing the unique challenges faced by smaller and emerging companies. Play Podcast Download Whitepaper For more information on how you can be featured in a podcast, contact Dan Limbach at [email protected] or call him at (847) 594-0157.
View all episodes
By Daniel LimbachDate Posted: 03/31/2010 Size: 6.64MB Length: 00:14:32 Thought Leader: Nicky Wisener, Biopharmaceutical Account Manager, Idis In this episode, Ms. Wisener describes how expanded access and named-patient programs can help successfully meet patients' needs while addressing the unique challenges faced by smaller and emerging companies. Play Podcast Download Whitepaper For more information on how you can be featured in a podcast, contact Dan Limbach at [email protected] or call him at (847) 594-0157.